Open AccessA Novel Small-Molecule Compound Targeting CCR5 and CXCR3 Prevents Acute and Chronic Allograft Rejection
Author(s) -
Satoru Akashi,
Masayuki Sho,
Hisanori Kashizuka,
Kaoru Hamada,
Naoya Ikeda,
Yukiyasu Kuzumoto,
Yoshikazu Tsurui,
Takeo Nomi,
Takashi Mizuno,
Hiromichi Kanehiro,
Michiyoshi Hisanaga,
Saiho Ko,
Yoshiyuki Nakajima
Publication year - 2005
Publication title -
transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.45
H-Index - 204
eISSN - 1534-6080
pISSN - 0041-1337
DOI - 10.1097/01.tp.0000166338.99933.e1
Subject(s) - cxcr3 , immunology , chemokine , chemokine receptor , ccr2 , transplantation , c c chemokine receptor type 7 , medicine , major histocompatibility complex , biology , immune system
Chemokines and chemokine receptors are critical in leukocyte recruitment, activation, and differentiation. Among them, CC chemokine receptor 5 (CCR5) and CXC chemokine receptor 3 (CXCR3) have been reported to play important roles in alloimmune responses and may be potential targets for posttransplant immunosuppression.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom